XM does not provide services to residents of the United States of America.
C
C

Clorox


News

U.S. Agenus, Guardant Health, Zoetis

U.S. RESEARCH ROUNDUP-Agenus, Guardant Health, Zoetis Aug 14 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Agenus, Guardant Health and Zoetis, on Wednesday. HIGHLIGHTS * Agenus Inc AGEN.O : B. Riley cuts target price to $18 from $42 * Clorox CLX.N : Jefferies raises target price to $151 from $148 * Guardant Health Inc GH.O : Raymond James raises target price to $36 from $28 * Starbucks SBUX.O : Stifel raises to buy
A
C
D
E
I
E
A
A
C
E

U.S. STOCKS Morgan Stanley, Intel, Guardant

BUZZ-U.S. STOCKS ON THE MOVE-Morgan Stanley, Intel, Guardant Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The Nasdaq Composite was set to plunge into a correction on Friday, falling more than 10% from its July peak after weak employment numbers aggravated worries of a slowdown in the U.S.
A
B
C
C
G
I
J
M
M
N
Q
A
U
A
M
U
U
C
C

U.S. Apple, Centerpoint Energy, Cummins

U.S. RESEARCH ROUNDUP-Apple, Centerpoint Energy, Cummins Aug 2 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including Apple, Centerpoint Energy and Cummins, on Friday. HIGHLIGHTS * Apple Inc AAPL.O : Wedbush raises target price to $285 from $275 * Centerpoint Energy CNP.N : JP Morgan cuts to neutral from overweight * Cummins CMI.N : Jefferies raises target price to $365 from $345 * Motorola MSI.N : JP Morgan raises target pr
A
A
B
B
I
K
M
A
B
C
A
A
A
A
C
C
L
M

Clorox up after annual profit forecast above estimates, Q4 profit beat

BUZZ-Clorox up after annual profit forecast above estimates, Q4 profit beat ** Shares of bleach maker Clorox CLX.N up ~4% at $140 after the bell ** Co forecasts annual profit above estimates owing to lower costs of manufacturing, logistics and commodity ** Expects FY25 profit in the range of $6.55 to $6.80 per share vs LSEG estimates of $6.45 per share ** Logs quarterly adj.
C

Clorox forecasts annual profit above estimates, beats fourth-quarter profit on lower input costs

Clorox forecasts annual profit above estimates, beats fourth-quarter profit on lower input costs Aug 1 (Reuters) - Bleach maker Clorox CLX.N forecast annual profit above estimates after beating fourth-quarter profit on Thursday, banking on consecutive price hikes of its home care products and easing input costs that improved margins . The demand for company's cleaning products such as floor cleaners and disinfectant sprays improved, as consumers prioritized shopping for daily essentials.
C

Clorox Co <CLX.N> expected to post earnings of $1.56 a share - Earnings Preview

Clorox Co expected to post earnings of $1.56 a share - Earnings Preview Clorox Co CLX.N , CLX is expected to show a fall in quarterly revenue when it reports results on August 1 for the period ending June 30 2024 The Oakland California-based company is expected to report a 3.4% decrease in revenue to $1.951 billion from $2.02 billion a year ago, according to the mean estimate from 13 analysts, based on LSEG data.
C

Clorox Increases Quarterly Dividend To $1.22 Per Share

BRIEF-Clorox Increases Quarterly Dividend To $1.22 Per Share July 30 (Reuters) - Clorox Co CLX.N : CLOROX INCREASES QUARTERLY DIVIDEND TO $1.22 PER SHARE Source text for Eikon: ID:nPn2JK9NDa Further company coverage: CLX.N
C

U.S. Colgate-Palmolive, McKesson, Microsoft

U.S. RESEARCH ROUNDUP-Colgate-Palmolive, McKesson, Microsoft July 23 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Colgate-Palmolive, McKesson and Microsoft, on Tuesday. HIGHLIGHTS * Colgate-Palmolive Co CL.N : TD Cowen initiates coverage with buy rating; PT $110 * DR Horton Inc DHI.N : JP Morgan raises target price to $180 from $163 * IQVIA Holdings Inc IQV.N : Baird raises target price to $251 from $235 * McKesso
C
H
M
M
T
V
Z
F
A
M
A
C
C
D
I



Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.